Patents
Patents for C07D 263 - Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings (20,978)
11/2004
11/24/2004EP1479666A1 Ester compound and medicinal use thereof
11/24/2004EP1479385A1 Use of cyclooxygenase-2 inhibitors in the treatment and prevention of neoplasia
11/24/2004EP1478631A1 Therapeutic compounds
11/24/2004EP1478630A2 Process and intermediates for preparing phenylthiomethyl-thiazoles or -oxazoles
11/24/2004EP1478629A1 N-aryl-2-oxazolidinone-5-carboxamides and their derivatives and their use as antibacterials
11/24/2004CN1549713A Diaryl cycloalkyl derivatives, the use thereof as PPAR activators and pharmaceutical compositions containing thereof
11/24/2004CN1176914C Intermediate for preparing 10-deacetylation baccatin III and 10-deacetylation-14 beta hydroxy baccatin III derivatives
11/24/2004CN1176910C Phenyl-and aminophenyl-alkylsulfonamide and urea derivatives
11/23/2004US6821972 3-heterocyclylpropanohydroxamic acid PCP inhibitors
11/23/2004US6821967 Amines such as 9-(4-(4-(benzothiazol-2-yl)-piperazin-1-yl)-butyl)-9h-fluorene-9-carboxylic acid (2,2,2-trifluoroethyl) amide, used as microsomal triglyceride transfer protein antagonists, to prevent atherosclerosis or hyperlipemia
11/18/2004WO2004099275A1 Azlactone chain transfer agents for radical polymerization
11/18/2004WO2004099175A2 Blockers of the quorum sensing system of gram-negative bacteria
11/18/2004WO2004099168A2 Substituted carboxylic acids
11/18/2004WO2004099165A2 Heterocyclic compounds and hydro isomers thereof
11/18/2004WO2004099134A2 Glutaminyl based dp iv-inhibitors
11/18/2004WO2004098592A1 Composition containing oxazolidinone derivative
11/18/2004WO2004098591A2 Inhibitors of glutaminyl cyclase and their use in the treatment of neurological diseases
11/18/2004WO2004098516A2 Cyclic derivatives as modulators of chemokine receptor activity
11/18/2004US20040230059 Forming acid salt, separating and neutralizing; high yield purification from acrylonitrile catalytic ammoxidation manufacturing
11/18/2004US20040229955 Antibacterial agents
11/18/2004US20040229946 Antidiabetic agents
11/18/2004US20040229910 Therapeutic compounds
11/18/2004US20040229899 Compounds useful in the treatment of conditions mediated by peroxisome proliferator-activated receptors (PPAR)
11/18/2004US20040229848 For therapy of non-insulin dependent diabetes
11/18/2004CA2526904A1 Blockers of the quorum sensing system of gram-negative bacteria
11/18/2004CA2523714A1 Substituted carboxylic acids
11/17/2004EP1477186A1 Antipruritics
11/17/2004EP1476447A1 Cyclic compounds and their use as complex ligands
11/17/2004EP1476423A2 Arylsulfonamidobenzylic compounds
11/17/2004EP1476419A2 N-biphenylmethyl aminocycloalkanecarboxamide derivatives
11/17/2004EP1042276B1 Thiourea compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
11/17/2004CN1176079C Process for prepn. of mesylates of piperazine derivatives
11/16/2004US6818644 Fluorene-9-carboxylic amides; inhibitors of microsomal triglyseride-transfer protein (mtp); antilipemic agents; atherosclerosis, diabetes, eating disorders, and pancreatitis
11/11/2004WO2004096784A1 New heterocyclic amides exhibiting an inhibitory activity at the vanilloid receptor 1 (vr1).
11/11/2004WO2004096757A1 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
11/11/2004WO2004096742A1 Hydroanthracene based compounds as anticancer agents
11/11/2004WO2004067675A3 Binaphthol based chromophores for the fabrication of blue organic light emitting diodes
11/11/2004US20040225091 Azlactone chain transfer agents for radical polymerization
11/11/2004US20040225013 Acylated 6,7,8,9-tetrahydro-5H-benzocycloheptenyl amines and their use as pharmaceutical agents
11/11/2004US20040224997 Preparation and use of aryl alkyl acid derivatives for the treatment of obesity
11/11/2004US20040224960 Pharmaceutical compositions and methods for their use
11/11/2004US20040224953 Fused bicyclic-substituted amines as histamine-3 receptor ligands
11/11/2004US20040224952 e.g., 4-{2-[2-(2-(R)-Methyl-pyrrolidin-1-yl)-ethyl]-benzothiazol-5-yl}-benzonitrile; useful for treating conditions and disorders related to memory and cognition processes, neurological processes, cardiovascular function, and body weight.
11/11/2004US20040224939 Antibacterial agents
11/11/2004US20040224875 Inhibitors of glutaminyl cyclase
11/11/2004US20040224257 Compound, photosensitive composition, lithographic printing plate precursor, and method of forming image
11/11/2004DE10317878A1 Verfahren zur Herstellung von alpha-methylierten Cystein und Serin-Derivaten A process for preparing alpha-methylated cysteine ​​and serine derivatives
11/11/2004CA2523677A1 Aminopropanol derivatives as sphingosine-1-phosphate receptor modulators
11/11/2004CA2523019A1 Hydroanthracene based compounds as anticancer agents
11/10/2004EP1475092A1 Blockers of the quorum sensing system of Gram-negative bacteria
11/10/2004EP1474382A1 Method for producing substituted 3-phenylamino-propane-1,2-diols
11/10/2004EP1474140A1 2-oxazolamines and their use as 5-ht2b receptor antagonists
11/10/2004EP1140181B1 Combination therapy of radiation and a cox-2 inhibitor for the treatment of neoplasia
11/10/2004CN1545428A Treatment for ocular infections
11/10/2004CN1174979C Piperazine and piperidine compounds
11/09/2004US6815460 Process for preparing prodrugs of benzenesulfonamide-containing cox-2 inhibitors
11/09/2004US6815445 Substituted diphenyloxazoles, the synthesis thereof, and the use thereof as fluorescence probes
11/04/2004WO2004094395A2 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers
11/04/2004WO2004094382A1 Muscarinic agonists
11/04/2004WO2004093879A1 (3-{3-‘(2,4-bis-trifluormethyl-benzyl)-(5-ethyl-pyrimidin-2-yl)-amino!-propoxy}-phenyl)-acetic acid and related compounds as modulators of ppars and methods of treating metabolic disorders
11/04/2004WO2004067506A3 Substituted heterocyclic compounds
11/04/2004WO2004067498A3 Aryl alkyl carbamate derivatives production and use thereof in therapy
11/04/2004WO2004067480A3 Substituted phenylurea derivatives as hdac inhibitors
11/04/2004WO2003077847A3 Substituted amides
11/04/2004US20040220407 Process to prepare oxazolidinones
11/04/2004US20040220256 Formed as enantiomers of cis-beta-phenylglycidic acid/beta-phenylisoserine react with nitrile compound via ritter reaction
11/04/2004US20040220244 PHOSPHOLIPASE INHIBITORS; use of inhibitor compositions in mammals to relieve sick conditions accompanied by enhanced PLA(2) activity such as inflammation, asthma, rhinitis, bronchitis, pneumonia, adult respiratory distress syndrome, inflammatory intestine disorder, Crohn's disease
11/04/2004US20040220243 optionally substituted thiazolyl, oxazolyl or pyrazolyl substituted heterocycles; use as pesticides and herbicides
11/04/2004US20040220236 4-Aryl quinols and analogs thereof as therapeutic agents
11/04/2004US20040220197 Hydroanthracene based compounds as anticancer agents
11/04/2004US20040220193 Nitrogen-containing cyclic compound and pharmaceutical composition containing the compound
11/04/2004CA2522476A1 Biaryl substituted thiazoles, oxazoles and imidazoles as sodium channel blockers
11/04/2004CA2520908A1 Aryl compounds as modulators of ppars and methods of treating metabolic disorders
11/04/2004CA2518324A1 Muscarinic agonists
11/03/2004EP1473286A1 Process for producing biaryl compound
11/03/2004EP1472237A1 Catechol bioisosteres
11/03/2004EP1472209A2 Lipoxin a4 analogs
11/03/2004EP1317461B1 4-cyclohexyl-1,3,2-oxazaborolidine chiral accessories
11/03/2004CN1173944C New vitamin-D derivatives with carbon ring or heterocyclic substitutents at C-25, process for the preparation, intermediate products and their use for producing medicaments
11/02/2004US6812237 (arylaminoaceamido)acetonitrile derivatives
11/02/2004CA2094806C Aminosulfonyl urea acat inhibitors
10/2004
10/28/2004WO2004092145A1 Alpha substituted carboxylic acid as ppar modulators
10/28/2004WO2004092131A1 Indole derivatives as ppar modulators
10/28/2004WO2004092119A2 Method for producing alpha-methylated cysteine and serine derivatives
10/28/2004WO2004092115A2 Hydroxamates as therapeutic agents
10/28/2004WO2004091604A1 Compounds that modulate ppar activity and methods of preparation
10/28/2004WO2004076386A3 Carbamic acid compounds comprising a bicyclic heteroaryl group as hdac inhibitors
10/28/2004WO2004071442A3 Novel bicyclic compounds and compositions
10/28/2004US20040214899 aqueous solutions of citric acid, disodium phosphate and (S)-4-{{3-[2-(dimethylaminoethyl]-1H-indol-5-yl]methyl]-2-oxazolidinone, used for prophylaxis of headaches; drug delivery devices; nasal sprays
10/28/2004US20040214896 drugs and/or prodrugs such as N-hydroxy-6-(4-(4-chlorophenyl)phenyl)-6-hydroxyhexanamide, used for prophylaxis of inflammatory disorders, cancers, psoriasis, diabetes, autoimmune diseases, hepatitis, graft versus host disease or endometriosis
10/28/2004US20040214890 1,3-diamino-2-hydroxypropane derivatives are useful as inhibitors of the beta-secretase enzyme that are useful in the treatment of Alzheimer's disease and other diseases characterized by deposition of A beta peptide in a mammal
10/28/2004US20040214869 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia
10/28/2004US20040214827 for the treatment and/or prevention of medical dysfunctions and diseases such as stroke, Parkinson's disease, and Alzheimer's disease caused by reactive oxygen species and/or excess Zn ions; neuroprotectants
10/28/2004CA2522118A1 Compounds that modulate ppar activity and methods of preparation
10/28/2004CA2521915A1 Alpha substituted carboxylic acid as ppar modulators
10/27/2004EP1471387A2 Photosensitive composition and compound used thereof
10/27/2004CN1539834A Method for preparing handy amino-tetrahydrofurans or its salts
10/27/2004CN1539832A Process for preparing oxazolines from tetrahydrofurans
10/27/2004CN1539831A Taxad alkyl derivative and its prepn. process
10/26/2004US6809203 Oxazolo, thiazolo and selenazolo [4,5-C]-quinolin-4-amines and analogs thereof
1 ... 78 79 80 81 82 83 84 85 86 87 88 89 90 91 92 93 94 95 96 97 98 ... 210